{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:06:37Z","timestamp":1781834797393,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801323"],"award-info":[{"award-number":["81801323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Science and Technology Talent training Project","award":["KJ20067"],"award-info":[{"award-number":["KJ20067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00702-021-02437-6","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T14:02:25Z","timestamp":1638021745000},"page":"563-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cognition, motor symptoms, and glycolipid metabolism in Parkinson\u2019s disease with depressive symptoms"],"prefix":"10.1007","volume":"129","author":[{"given":"Cong","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"issue":"12","key":"2437_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/s1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15(12):1257\u20131272. https:\/\/doi.org\/10.1016\/s1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"issue":"2","key":"2437_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3233\/jpd-191882","volume":"10","author":"R Bakshi","year":"2020","unstructured":"Bakshi R, Macklin EA, Hung AY, Hayes MT, Hyman BT, Wills AM, Schwarzschild MA (2020) Associations of lower caffeine intake and plasma urate levels with idiopathic Parkinson\u2019s disease in the Harvard biomarkers study. J Parkinsons Dis 10(2):505\u2013510. https:\/\/doi.org\/10.3233\/jpd-191882","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"2437_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","volume":"268","author":"F Bartoli","year":"2018","unstructured":"Bartoli F, Trotta G, Crocamo C, Malerba MR, Clerici M, Carra G (2018) Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression. Eur Arch Psychiatry Clin Neurosci 268(2):119\u2013127. https:\/\/doi.org\/10.1007\/s00406-017-0817-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"2437_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/wps.20248","volume":"14","author":"P Bech","year":"2015","unstructured":"Bech P (2015) The responsiveness of the different versions of the Hamilton depression scale. World Psychiatry 14(3):309\u2013310. https:\/\/doi.org\/10.1002\/wps.20248","journal-title":"World Psychiatry"},{"key":"2437_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jad.2017.09.003","volume":"225","author":"CN Black","year":"2018","unstructured":"Black CN, Bot M, Scheffer PG, Snieder H, Penninx B (2018) Uric acid in major depressive and anxiety disorders. J Affect Disord 225:684\u2013690. https:\/\/doi.org\/10.1016\/j.jad.2017.09.003","journal-title":"J Affect Disord"},{"issue":"1","key":"2437_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12020-016-0869-x","volume":"53","author":"S Chen","year":"2016","unstructured":"Chen S, Zhang Q, Dai G, Hu J, Zhu C, Su L, Wu X (2016) Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis. Endocrine 53(1):35\u201346. https:\/\/doi.org\/10.1007\/s12020-016-0869-x","journal-title":"Endocrine"},{"issue":"3","key":"2437_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.08.006","volume":"47","author":"HS Chung","year":"2021","unstructured":"Chung HS, Lee JS, Kim JA, Roh E, Lee YB, Hong SH, Choi KM (2021) Fasting plasma glucose variability in midlife and risk of Parkinson\u2019s disease: a nationwide population-based study. Diabetes Metab 47(3):101195. https:\/\/doi.org\/10.1016\/j.diabet.2020.08.006","journal-title":"Diabetes Metab"},{"issue":"2","key":"2437_CR8","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/ane.12012","volume":"127","author":"R Constantinescu","year":"2013","unstructured":"Constantinescu R, Andreasson U, Holmberg B, Zetterberg H (2013) Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies. Acta Neurol Scand 127(2):e8-12. https:\/\/doi.org\/10.1111\/ane.12012","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2437_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11910-016-0647-4","volume":"16","author":"JW Cooney","year":"2016","unstructured":"Cooney JW, Stacy M (2016) Neuropsychiatric issues in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 16(5):49. https:\/\/doi.org\/10.1007\/s11910-016-0647-4","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"2437_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s1474-4422(06)70471-9","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. https:\/\/doi.org\/10.1016\/s1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"5","key":"2437_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.20663","volume":"58","author":"LM de Lau","year":"2005","unstructured":"de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2005) Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58(5):797\u2013800. https:\/\/doi.org\/10.1002\/ana.20663","journal-title":"Ann Neurol"},{"issue":"10","key":"2437_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","volume":"15","author":"A De Virgilio","year":"2016","unstructured":"De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, de Vincentiis M (2016) Parkinson\u2019s disease: autoimmunity and neuroinflammation. Autoimmun Rev 15(10):1005\u20131011. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.022","journal-title":"Autoimmun Rev"},{"key":"2437_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnmol.2018.00257","volume":"11","author":"MX Dong","year":"2018","unstructured":"Dong MX, Feng X, Xu XM, Hu L, Liu Y, Jia SY, Wei YD (2018) Integrated analysis reveals altered lipid and glucose metabolism and identifies NOTCH2 as a biomarker for Parkinson\u2019s disease related depression. Front Mol Neurosci 11:257. https:\/\/doi.org\/10.3389\/fnmol.2018.00257","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2437_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz A, Carcaillon L, Kab S, Moisan F (2016) Epidemiology of Parkinson\u2019s disease. Rev Neurol (paris) 172(1):14\u201326. https:\/\/doi.org\/10.1016\/j.neurol.2015.09.012","journal-title":"Rev Neurol (paris)"},{"issue":"1","key":"2437_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12944-020-01284-w","volume":"19","author":"X Fu","year":"2020","unstructured":"Fu X, Wang Y, He X, Li H, Liu H, Zhang X (2020) A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson\u2019s disease. Lipids Health Dis 19(1):97. https:\/\/doi.org\/10.1186\/s12944-020-01284-w","journal-title":"Lipids Health Dis"},{"issue":"3","key":"2437_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","volume":"46","author":"DA Gallagher","year":"2012","unstructured":"Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson\u2019s disease. Neurobiol Dis 46(3):581\u2013589. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.041","journal-title":"Neurobiol Dis"},{"issue":"6","key":"2437_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","volume":"86","author":"X Gao","year":"2016","unstructured":"Gao X, O\u2019Reilly EJ, Schwarzschild MA, Ascherio A (2016) Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86(6):520\u2013526. https:\/\/doi.org\/10.1212\/WNL.0000000000002351","journal-title":"Neurology"},{"issue":"4","key":"2437_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/wco.0000000000000112","volume":"27","author":"JG Goldman","year":"2014","unstructured":"Goldman JG, Postuma R (2014) Premotor and nonmotor features of Parkinson\u2019s disease. Curr Opin Neurol 27(4):434\u2013441. https:\/\/doi.org\/10.1097\/wco.0000000000000112","journal-title":"Curr Opin Neurol"},{"key":"2437_CR19","doi-asserted-by":"crossref","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56\u201362. Retrieved from https:\/\/pubmed.ncbi.nlm.nih.gov\/14399272","DOI":"10.1136\/jnnp.23.1.56"},{"issue":"4","key":"2437_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ppe.12199","volume":"29","author":"T Huang","year":"2015","unstructured":"Huang T, Rifas-Shiman SL, Ertel KA, Rich-Edwards J, Kleinman K, Gillman MW, James-Todd T (2015a) Pregnancy hyperglycaemia and risk of prenatal and postpartum depressive symptoms. Paediatr Perinat Epidemiol 29(4):281\u2013289. https:\/\/doi.org\/10.1111\/ppe.12199","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"2437_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mds.26152","volume":"30","author":"X Huang","year":"2015","unstructured":"Huang X, Alonso A, Guo X, Umbach DM, Lichtenstein ML, Ballantyne CM, Chen H (2015b) Statins, plasma cholesterol, and risk of Parkinson\u2019s disease: a prospective study. Mov Disord 30(4):552\u2013559. https:\/\/doi.org\/10.1002\/mds.26152","journal-title":"Mov Disord"},{"issue":"4","key":"2437_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.bbrc.2017.10.004","volume":"493","author":"TT Huang","year":"2017","unstructured":"Huang TT, Hao DL, Wu BN, Mao LL, Zhang J (2017) Uric acid demonstrates neuroprotective effect on Parkinson\u2019s disease mice through Nrf2-ARE signaling pathway. Biochem Biophys Res Commun 493(4):1443\u20131449. https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.004","journal-title":"Biochem Biophys Res Commun"},{"key":"2437_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","volume":"55","author":"XX Huang","year":"2018","unstructured":"Huang XX, Ng SYE, Chia NSY, Acharyya S, Setiawan F, Lu ZH, Tan LCS (2018) Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study. Parkinsonism Relat Disord 55:50\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2437_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.23750\/abm.v88i3.6063","volume":"88","author":"AJ Jagadeesan","year":"2017","unstructured":"Jagadeesan AJ, Murugesan R, Vimala Devi S, Meera M, Madhumala G, Vishwanathan Padmaja M, Pathak S (2017) Current trends in etiology, prognosis and therapeutic aspects of Parkinson\u2019s disease: a review. Acta Biomed 88(3):249\u2013262. https:\/\/doi.org\/10.23750\/abm.v88i3.6063","journal-title":"Acta Biomed"},{"issue":"4","key":"2437_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000327748","volume":"36","author":"S Jain","year":"2011","unstructured":"Jain S, Ton TG, Boudreau RM, Yang M, Thacker EL, Studenski S, Newman AB (2011) The risk of Parkinson disease associated with urate in a community-based cohort of older adults. Neuroepidemiology 36(4):223\u2013229. https:\/\/doi.org\/10.1159\/000327748","journal-title":"Neuroepidemiology"},{"issue":"2","key":"2437_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3233\/jpd-171257","volume":"8","author":"AM Keener","year":"2018","unstructured":"Keener AM, Paul KC, Folle A, Bronstein JM, Ritz B (2018) Cognitive impairment and mortality in a population-based Parkinson\u2019s disease cohort. J Parkinsons Dis 8(2):353\u2013362. https:\/\/doi.org\/10.3233\/jpd-171257","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"2437_CR27","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.2337\/dc20-1561","volume":"43","author":"LV Kessing","year":"2020","unstructured":"Kessing LV, Rytgaard HC, Ekstr\u00f8m CT, Knop FK, Berk M, Gerds TA (2020) Antidiabetes agents and incident depression: a nationwide population-based study. Diabetes Care 43(12):3050\u20133060. https:\/\/doi.org\/10.2337\/dc20-1561","journal-title":"Diabetes Care"},{"issue":"2","key":"2437_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/ana.25294","volume":"84","author":"DA Kia","year":"2018","unstructured":"Kia DA, Noyce AJ, White J, Speed D, Nicolas A, Burgess S, Collaborators, I (2018) Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson\u2019s disease. Annal Neurol 84(2):191\u2013199. https:\/\/doi.org\/10.1002\/ana.25294","journal-title":"Annal Neurol"},{"issue":"2","key":"2437_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.25292","volume":"84","author":"CJ Kobylecki","year":"2018","unstructured":"Kobylecki CJ, Nordestgaard BG, Afzal S (2018) Plasma urate and risk of Parkinson\u2019s disease: A mendelian randomization study. Ann Neurol 84(2):178\u2013190. https:\/\/doi.org\/10.1002\/ana.25292","journal-title":"Ann Neurol"},{"issue":"7","key":"2437_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/1570159x14666151208113700","volume":"14","author":"O Kohler","year":"2016","unstructured":"Kohler O, Krogh J, Mors O, Benros ME (2016a) Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol 14(7):732\u2013742. https:\/\/doi.org\/10.2174\/1570159x14666151208113700","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"2437_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0269881115609072","volume":"30","author":"S Kohler","year":"2016","unstructured":"Kohler S, Cierpinsky K, Kronenberg G, Adli M (2016b) The serotonergic system in the neurobiology of depression: relevance for novel antidepressants. J Psychopharmacol 30(1):13\u201322. https:\/\/doi.org\/10.1177\/0269881115609072","journal-title":"J Psychopharmacol"},{"issue":"8","key":"2437_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1530\/ec-17-0200","volume":"6","author":"J L\u00e9ger","year":"2017","unstructured":"L\u00e9ger J, Fjellestad-Paulsen A, Bargiacchi A, Doyen C, Ecosse E, Carel JC, Le Heuzey MF (2017) Can growth hormone treatment improve growth in children with severe growth failure due to anorexia nervosa? A preliminary pilot study. Endocr Connect 6(8):839\u2013846. https:\/\/doi.org\/10.1530\/ec-17-0200","journal-title":"Endocr Connect"},{"issue":"10","key":"2437_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/13548506.2019.1622748","volume":"24","author":"YR Li","year":"2019","unstructured":"Li YR, Zhao LY, Yu DM, Ding GQ (2019) Associations between serum uric acid and depression among middle-aged and elderly participants in China. Psychol Health Med 24(10):1277\u20131286. https:\/\/doi.org\/10.1080\/13548506.2019.1622748","journal-title":"Psychol Health Med"},{"issue":"Suppl 1","key":"2437_CR34","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1002\/mds.22786","volume":"25","author":"SY Lim","year":"2010","unstructured":"Lim SY, Lang AE (2010) The nonmotor symptoms of Parkinson\u2019s disease\u2014an overview. Mov Disord 25(Suppl 1):S123-130. https:\/\/doi.org\/10.1002\/mds.22786","journal-title":"Mov Disord"},{"issue":"4","key":"2437_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/08919887211018267","volume":"34","author":"H Lintel","year":"2021","unstructured":"Lintel H, Corpuz T, Paracha SUR, Grossberg GT (2021) Mood disorders and anxiety in Parkinson\u2019s disease: current concepts. J Geriatr Psychiatry Neurol 34(4):280\u2013288. https:\/\/doi.org\/10.1177\/08919887211018267","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"2437_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement disorder society task force guidelines. Mov Disord 27(3):349\u2013356. https:\/\/doi.org\/10.1002\/mds.24893","journal-title":"Mov Disord"},{"issue":"5","key":"2437_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25338","volume":"28","author":"S Lord","year":"2013","unstructured":"Lord S, Galna B, Coleman S, Burn D, Rochester L (2013) Mild depressive symptoms are associated with gait impairment in early Parkinson\u2019s disease. Mov Disord 28(5):634\u2013639. https:\/\/doi.org\/10.1002\/mds.25338","journal-title":"Mov Disord"},{"key":"2437_CR38","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jad.2020.09.032","volume":"277","author":"M Lubomski","year":"2020","unstructured":"Lubomski M, Davis RL, Sue CM (2020) Depression in Parkinson\u2019s disease: perspectives from an Australian cohort. J Affect Disord 277:1038\u20131044. https:\/\/doi.org\/10.1016\/j.jad.2020.09.032","journal-title":"J Affect Disord"},{"issue":"6","key":"2437_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ (2018) Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol 17(6):559\u2013568. https:\/\/doi.org\/10.1016\/s1474-4422(18)30127-3","journal-title":"Lancet Neurol"},{"key":"2437_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228421","author":"C Marogianni","year":"2020","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G (2020) Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228421","journal-title":"Int J Mol Sci"},{"key":"2437_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.parkreldis.2018.05.026","volume":"55","author":"A Marques","year":"2018","unstructured":"Marques A, Dutheil F, Durand E, Rieu I, Mulliez A, Fantini ML, Durif F (2018) Glucose dysregulation in Parkinson\u2019s disease: too much glucose or not enough insulin? Parkinsonism Relat Disord 55:122\u2013127. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.026","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"2437_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh L (2013) Depression and Parkinson\u2019s disease: current knowledge. Curr Neurol Neurosci Rep 13(12):409. https:\/\/doi.org\/10.1007\/s11910-013-0409-5","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"2437_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.25846","volume":"29","author":"B Mollenhauer","year":"2014","unstructured":"Mollenhauer B, Rochester L, Chen-Plotkin A, Brooks D (2014) What can biomarkers tell us about cognition in Parkinson\u2019s disease? Mov Disord 29(5):622\u2013633. https:\/\/doi.org\/10.1002\/mds.25846","journal-title":"Mov Disord"},{"issue":"4","key":"2437_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"2437_CR45","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.parkreldis.2015.06.014","volume":"21","author":"A Ng","year":"2015","unstructured":"Ng A, Chander RJ, Tan LC, Kandiah N (2015) Influence of depression in mild Parkinson\u2019s disease on longitudinal motor and cognitive function. Parkinsonism Relat Disord 21(9):1056\u20131060. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.014","journal-title":"Parkinsonism Relat Disord"},{"key":"2437_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jocn.2019.01.021","volume":"63","author":"K Nie","year":"2019","unstructured":"Nie K, Gao Y, Mei M, Guo M, Huang Z, Wang L, Wang L (2019) The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson\u2019s disease and the analysis of relevant factors. J Clin Neurosci 63:142\u2013148. https:\/\/doi.org\/10.1016\/j.jocn.2019.01.021","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2437_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.clineuro.2005.08.002","volume":"108","author":"S Papapetropoulos","year":"2006","unstructured":"Papapetropoulos S, Ellul J, Argyriou AA, Chroni E, Lekka NP (2006) The effect of depression on motor function and disease severity of Parkinson\u2019s disease. Clin Neurol Neurosurg 108(5):465\u2013469. https:\/\/doi.org\/10.1016\/j.clineuro.2005.08.002","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"2437_CR48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"1","key":"2437_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mds.27836","volume":"35","author":"J Potashkin","year":"2020","unstructured":"Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C (2020) Understanding the links between cardiovascular disease and Parkinson\u2019s disease. Mov Disord 35(1):55\u201374. https:\/\/doi.org\/10.1002\/mds.27836","journal-title":"Mov Disord"},{"issue":"1","key":"2437_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0253-7613.150305","volume":"47","author":"V Prabhakar","year":"2015","unstructured":"Prabhakar V, Gupta D, Kanade P, Radhakrishnan M (2015) Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Ind J Pharmacol 47(1):4\u201310. https:\/\/doi.org\/10.4103\/0253-7613.150305","journal-title":"Ind J Pharmacol"},{"issue":"7","key":"2437_CR51","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","volume":"257","author":"O Riedel","year":"2010","unstructured":"Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Wittchen HU (2010) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1449 outpatients with Parkinson\u2019s disease. J Neurol 257(7):1073\u20131082. https:\/\/doi.org\/10.1007\/s00415-010-5465-z","journal-title":"J Neurol"},{"issue":"2","key":"2437_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/jpd-181306","volume":"8","author":"M Roheger","year":"2018","unstructured":"Roheger M, Kalbe E, Liepelt-Scarfone I (2018) Progression of cognitive decline in Parkinson\u2019s disease. J Parkinsons Dis 8(2):183\u2013193. https:\/\/doi.org\/10.3233\/jpd-181306","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"2437_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.598","volume":"7","author":"H Sakuta","year":"2017","unstructured":"Sakuta H, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Hirata K (2017) Serum uric acid levels in Parkinson\u2019s disease and related disorders. Brain Behav 7(1):e00598. https:\/\/doi.org\/10.1002\/brb3.598","journal-title":"Brain Behav"},{"issue":"4","key":"2437_CR54","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00702-015-1503-4","volume":"123","author":"R Sampat","year":"2016","unstructured":"Sampat R, Young S, Rosen A, Bernhard D, Millington D, Factor S, Jinnah HA (2016) Potential mechanisms for low uric acid in Parkinson disease. J Neural Transm (vienna) 123(4):365\u2013370. https:\/\/doi.org\/10.1007\/s00702-015-1503-4","journal-title":"J Neural Transm (vienna)"},{"issue":"11","key":"2437_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142582","volume":"10","author":"JA Santiago","year":"2015","unstructured":"Santiago JA, Potashkin JA (2015) Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson\u2019s disease patients. PLoS ONE 10(11):e0142582. https:\/\/doi.org\/10.1371\/journal.pone.0142582","journal-title":"PLoS ONE"},{"key":"2437_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.04.020","volume":"65","author":"D Saredakis","year":"2019","unstructured":"Saredakis D, Collins-Praino LE, Gutteridge DS, Stephan BCM, Keage HAD (2019) Conversion to MCI and dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 65:20\u201331. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.020","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"2437_CR57","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4103\/1673-5374.156958","volume":"10","author":"JC Schlachetzki","year":"2015","unstructured":"Schlachetzki JC, Winkler J (2015) The innate immune system in Parkinson\u2019s disease: a novel target promoting endogenous neuroregeneration. Neural Regen Res 10(5):704\u2013706. https:\/\/doi.org\/10.4103\/1673-5374.156958","journal-title":"Neural Regen Res"},{"key":"2437_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/bs.irn.2017.05.024","volume":"133","author":"A Schrag","year":"2017","unstructured":"Schrag A, Taddei RN (2017) Depression and anxiety in Parkinson\u2019s disease. Int Rev Neurobiol 133:623\u2013655. https:\/\/doi.org\/10.1016\/bs.irn.2017.05.024","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"2437_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"2437_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00702-018-1947-4","volume":"126","author":"NM Soares","year":"2019","unstructured":"Soares NM, Pereira GM, Altmann V, de Almeida RMM, Rieder CRM (2019) Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson\u2019s disease: a systematic review. J Neural Transm (vienna) 126(3):219\u2013232. https:\/\/doi.org\/10.1007\/s00702-018-1947-4","journal-title":"J Neural Transm (vienna)"},{"issue":"8","key":"2437_CR61","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (vienna) 124(8):901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y","journal-title":"J Neural Transm (vienna)"},{"issue":"2","key":"2437_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, van den Heuvel OA (2014) Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159\u2013164. https:\/\/doi.org\/10.1136\/jnnp-2012-304811","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2437_CR63","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00702-014-1313-0","volume":"122","author":"U Walter","year":"2015","unstructured":"Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R, H\u00f6ppner J (2015) Prediction of Parkinson\u2019s disease subsequent to severe depression: a ten-year follow-up study. J Neural Transm (vienna) 122(6):789\u2013797. https:\/\/doi.org\/10.1007\/s00702-014-1313-0","journal-title":"J Neural Transm (vienna)"},{"key":"2437_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","volume":"86","author":"S Wang","year":"2018","unstructured":"Wang S, Mao S, Xiang D, Fang C (2018) Association between depression and the subsequent risk of Parkinson\u2019s disease: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 86:186\u2013192. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"2437_CR65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1750-3639.2010.00373.x","volume":"20","author":"GS Watson","year":"2010","unstructured":"Watson GS, Leverenz JB (2010) Profile of cognitive impairment in Parkinson\u2019s disease. Brain Pathol 20(3):640\u2013645. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00373.x","journal-title":"Brain Pathol"},{"issue":"3","key":"2437_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173731","volume":"12","author":"M Wen","year":"2017","unstructured":"Wen M, Zhou B, Chen YH, Ma ZL, Gou Y, Zhang CL, Jiao L (2017) Serum uric acid levels in patients with Parkinson\u2019s disease: a meta-analysis. PLoS ONE 12(3):e0173731. https:\/\/doi.org\/10.1371\/journal.pone.0173731","journal-title":"PLoS ONE"},{"issue":"7","key":"2437_CR67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/gps.4878","volume":"33","author":"M Xiao","year":"2018","unstructured":"Xiao M, Wang Q, Ren W, Zhang Z, Wu X, Wang Z, He J (2018) Impact of prediabetes on poststroke depression in Chinese patients with acute ischemic stroke. Int J Geriatr Psychiatry 33(7):956\u2013963. https:\/\/doi.org\/10.1002\/gps.4878","journal-title":"Int J Geriatr Psychiatry"},{"key":"2437_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fnagi.2017.00355","volume":"9","author":"L Yang","year":"2017","unstructured":"Yang L, Chen Z, Li B, Wang M, Yu L, Wan Y, Wang X (2017) Multiple evidences for association between cognitive impairment and dysglycemia in Parkinson\u2019s disease: implications for clinical practice. Front Aging Neurosci 9:355. https:\/\/doi.org\/10.3389\/fnagi.2017.00355","journal-title":"Front Aging Neurosci"},{"key":"2437_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-244x-12-156","volume":"12","author":"J Yu","year":"2012","unstructured":"Yu J, Li J, Huang X (2012) The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry 12:156. https:\/\/doi.org\/10.1186\/1471-244x-12-156","journal-title":"BMC Psychiatry"},{"issue":"6","key":"2437_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MBP.0000000000000404","volume":"24","author":"YX Zhang","year":"2019","unstructured":"Zhang YX, Wang SR (2019) Large body mass index and waist circumference are associated with high blood pressure and impaired fasting glucose in young Chinese men. Blood Press Monit 24(6):289\u2013293. https:\/\/doi.org\/10.1097\/MBP.0000000000000404","journal-title":"Blood Press Monit"},{"issue":"6","key":"2437_CR71","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00415-016-8130-3","volume":"263","author":"KD Zhu","year":"2016","unstructured":"Zhu KD, van Hilten JJ, Marinus J (2016) Associated and predictive factors of depressive symptoms in patients with Parkinson\u2019s disease. J Neurol 263(6):1215\u20131225. https:\/\/doi.org\/10.1007\/s00415-016-8130-3","journal-title":"J Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02437-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02437-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02437-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T13:11:06Z","timestamp":1654953066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02437-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":71,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02437-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}